Collegium Pharmaceutical, Inc. Investment Income, Interest
Collegium Pharmaceutical, Inc. (COLL) reported Investment Income, Interest of $3.12 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2025-11-06
- Collegium Pharmaceutical, Inc. investment income, interest for the quarter ending 2025-09-30 was $3.12M, a 5.00% decline year-over-year.
- Collegium Pharmaceutical, Inc. investment income, interest for the quarter ending 2025-06-30 was $2.38M, a 45.80% decline year-over-year.
- Collegium Pharmaceutical, Inc. investment income, interest for the quarter ending 2025-03-31 was $2.23M, a 50.41% decline year-over-year.
- Collegium Pharmaceutical, Inc. investment income, interest for the quarter ending 2024-09-30 was $3.28M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month |
|---|---|---|---|
| 2025-09-30 | $3.12M 10-Q · filed 2025-11-06 | $5.50M derived: sum of 2 quarters · filed 2025-11-06 | $7.72M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $2.38M 10-Q · filed 2025-08-07 | $4.61M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $2.23M 10-Q · filed 2025-05-08 | ||
| 2024-09-30 | $3.28M 10-Q · filed 2025-11-06 | $7.68M derived: sum of 2 quarters · filed 2025-11-06 | $12.16M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $4.40M 10-Q · filed 2025-08-07 | $8.88M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $4.49M 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |